comparemela.com

Latest Breaking News On - Percutaneous coronary intervention - Page 1 : comparemela.com

Elixir Medical's Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World's First Site-Specific Antithrombotic Therapeutic Compared to DES

DESyne BDS Plus system with site-specific antithrombotic therapeutic (TRx) significantly reduced the risk of TLF versus conventional drug-eluting stent through 12-months

New-zealand
Sao-paulo
Sãpaulo
Brazil
Paris
France-general
France
United-states
Alexandran-nowbar
Jamesp-howard
Michael-foley
Kui-hong

Elixir Medical Corporation: EuroPCR 2024: Elixir Medical's Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World's First Site-Specific Antithrombotic Therapeutic Compared to DES

Elixir Medical Corporation: EuroPCR 2024: Elixir Medical's Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World's First Site-Specific Antithrombotic Therapeutic Compared to DES
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Paris
France-general
France
Sao-paulo
Sãpaulo
Brazil
New-zealand
Milpitas
California
United-states
Liza-chacko
Alexandre-abizaid

AdventHealth Gordon receives PCI Accreditation from Corazon

AdventHealth Gordon receives PCI Accreditation from Corazon
coosavalleynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coosavalleynews.com Daily Mail and Mail on Sunday newspapers.

Georgia
United-states
Pennsylvania
Adventhealth-murray
Adventhealth-gordon
Edward-pelote
Georgia-department-of-community-health
Corazon-inc
Percutaneous-coronary-intervention
Georgia-department
Community-health
Health-gordon
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.